• 1
    Prlic, M., Williams, M. A. and Bevan, M. J., Requirements for CD8 T-cell priming, memory generation and maintenance. Curr. Opin. Immunol. 2007. 19: 315319.
  • 2
    Cox, M. A. and Zajac, A. J., Shaping successful and unsuccessful CD8 T cell responses following infection. J. Biomed. Biotechnol. 2010. 2010: 159152.
  • 3
    DiSpirito, J. R. and Shen, H., Quick to remember, slow to forget: rapid recall responses of memory CD8+T cells. Cell Res. 2010. 20: 1323.
  • 4
    Tham, E. L. and Mescher, M. F., The poststimulation program of CD4 versus CD8 T cells (death versus activation-induced nonresponsiveness). J. Immunol. 2002. 169: 18221828.
  • 5
    Zhu, J. and Paul, W. E., Heterogeneity and plasticity of T helper cells. Cell Res. 2010. 20: 412.
  • 6
    Pflanz, S., Timans, J. C., Cheung, J., Rosales, R., Kanzler, H., Gilbert, J., Hibbert, L. et al., IL-27, a heterodimeric cytokine composed of EBI3 and p28 protein, induces proliferation of naive CD4(+) T cells. Immunity 2002. 16: 779790.
  • 7
    Wirtz, S., Becker, C., Fantini, M. C., Nieuwenhuis, E. E., Tubbe, I., Galle, P. R., Schild, H. J. et al., EBV-induced gene 3 transcription is induced by TLR signaling in primary dendritic cells via NF-kappa B activation. J. Immunol. 2005. 174: 28142824.
  • 8
    Yoshida, H., Miyazaki, Y., Wang, S. and Hamano, S., Regulation of defense responses against protozoan infection by interleukin-27 and related cytokines. J. Biomed. Biotechnol. 2007. 2007: 79401.
  • 9
    Chen, Q., Ghilardi, N., Wang, H., Baker, T., Xie, M. H., Gurney, A., Grewal, I. S. et al., Development of Th1-type immune responses requires the type I cytokine receptor TCCR. Nature 2000. 407: 916920.
  • 10
    Yoshida, H., Hamano, S., Senaldi, G., Covey, T., Faggioni, R., Mu, S., Xia, M. et al., WSX-1 is required for the initiation of Th1 responses and resistance to L. major infection. Immunity 2001. 15: 569578.
  • 11
    Diveu, C., McGeachy, M. J., Boniface, K., Stumhofer, J. S., Sathe, M., Joyce-Shaikh, B., Chen, Y. et al., IL-27 blocks RORc expression to inhibit lineage commitment of Th17 cells. J Immunol 2009. 182: 57485756.
  • 12
    Villarino, A. V., Stumhofer, J. S., Saris, C. J., Kastelein, R. A., de Sauvage, F. J. and Hunter, C. A., IL-27 limits IL-2 production during Th1 differentiation. J. Immunol. 2006. 176: 237247.
  • 13
    Awasthi, A., Carrier, Y., Peron, J. P., Bettelli, E., Kamanaka, M., Flavell, R. A., Kuchroo, V. K. et al., A dominant function for interleukin 27 in generating interleukin 10-producing anti-inflammatory T cells. Nat. Immunol. 2007. 8: 13801389.
  • 14
    Fitzgerald, D. C., Zhang, G. X., El-Behi, M., Fonseca-Kelly, Z., Li, H., Yu, S., Saris, C. J. et al., Suppression of autoimmune inflammation of the central nervous system by interleukin 10 secreted by interleukin 27-stimulated T cells. Nat. Immunol. 2007. 8: 13721379.
  • 15
    Stumhofer, J. S., Silver, J. S., Laurence, A., Porrett, P. M., Harris, T. H., Turka, L. A., Ernst, M. et al., Interleukins 27 and 6 induce STAT3-mediated T cell production of interleukin 10. Nat. Immunol. 2007. 8: 13631371.
  • 16
    Murugaiyan, G., Mittal, A., Lopez-Diego, R., Maier, L. M., Anderson, D. E. and Weiner, H. L., IL-27 is a key regulator of IL-10 and IL-17 production by human CD4+T cells. J. Immunol. 2009. 183: 24352443.
  • 17
    Matsui, M., Moriya, O., Belladonna, M. L., Kamiya, S., Lemonnier, F. A., Yoshimoto, T. and Akatsuka, T., Adjuvant activities of novel cytokines, interleukin-23 (IL-23) and IL-27, for induction of hepatitis C virus-specific cytotoxic T lymphocytes in HLA-A*0201 transgenic mice. J. Virol. 2004. 78: 90939104.
  • 18
    Morishima, N., Owaki, T., Asakawa, M., Kamiya, S., Mizuguchi, J. and Yoshimoto, T., Augmentation of effector CD8+T cell generation with enhanced granzyme B expression by IL-27. J. Immunol. 2005. 175: 16861693.
  • 19
    Brender, C., Tannahill, G. M., Jenkins, B. J., Fletcher, J., Columbus, R., Saris, C. J., Ernst, M. et al., Suppressor of cytokine signaling 3 regulates CD8 T-cell proliferation by inhibition of interleukins 6 and 27. Blood 2007. 110: 25282536.
  • 20
    Hibbert, L., Pflanz, S., De Waal Malefyt, R. and Kastelein, R. A., IL-27 and IFN-alpha signal via Stat1 and Stat3 and induce T-Bet and IL-12Rbeta2 in naive T cells. J. Interferon Cytokine Res. 2003. 23: 513522.
  • 21
    Lucas, S., Ghilardi, N., Li, J. and de Sauvage, F. J., IL-27 regulates IL-12 responsiveness of naive CD4+T cells through Stat1-dependent and -independent mechanisms. Proc. Natl. Acad. Sci. USA 2003. 100: 1504715052.
  • 22
    Pflanz, S., Hibbert, L., Mattson, J., Rosales, R., Vaisberg, E., Bazan, J. F., Phillips, J. H. et al., WSX-1 and glycoprotein 130 constitute a signal-transducing receptor for IL-27. J. Immunol. 2004. 172: 22252231.
  • 23
    Villarino, A. V., Larkin, J., 3rd, Saris, C. J., Caton, A. J., Lucas, S., Wong, T., de Sauvage, F. J. et al., Positive and negative regulation of the IL-27 receptor during lymphoid cell activation. J. Immunol. 2005. 174: 76847691.
  • 24
    Li, J., Gran, B., Zhang, G. X., Rostami, A. and Kamoun, M., IL-27 subunits and its receptor (WSX-1) mRNAs are markedly up-regulated in inflammatory cells in the CNS during experimental autoimmune encephalomyelitis. J. Neurol. Sci. 2005. 232: 39.
  • 25
    Batten, M., Li, J., Yi, S., Kljavin, N. M., Danilenko, D. M., Lucas, S., Lee, J. et al., Interleukin 27 limits autoimmune encephalomyelitis by suppressing the development of interleukin 17-producing T cells. Nat. Immunol. 2006. 7: 929936.
  • 26
    Larousserie, F., Pflanz, S., Coulomb-L'Hermine, A., Brousse, N., Kastelein, R. and Devergne, O., Expression of IL-27 in human Th1-associated granulomatous diseases. J. Pathol. 2004. 202: 164171.
  • 27
    Kalliolias, G. D. and Ivashkiv, L. B., IL-27 activates human monocytes via STAT1 and suppresses IL-10 production but the inflammatory functions of IL-27 are abrogated by TLRs and p38. J. Immunol. 2008. 180: 63256333.
  • 28
    Betz, U. A. and Muller, W., Regulated expression of gp130 and IL-6 receptor alpha chain in T cell maturation and activation. Int. Immunol. 1998. 10: 11751184.
  • 29
    Mahic, M., Kalland, M. E., Aandahl, E. M., Torgersen, K. M. and Tasken, K., Human naturally occurring and adaptive regulatory T cells secrete high levels of leukaemia inhibitory factor upon activation. Scand. J. Immunol. 2008. 68: 391396.
  • 30
    Owaki, T., Asakawa, M., Morishima, N., Mizoguchi, I., Fukai, F., Takeda, K., Mizuguchi, J. et al., STAT3 is indispensable to IL-27-mediated cell proliferation but not to IL-27-induced Th1 differentiation and suppression of proinflammatory cytokine production. J. Immunol. 2008. 180: 29032911.
  • 31
    Takeda, A., Hamano, S., Yamanaka, A., Hanada, T., Ishibashi, T., Mak, T. W., Yoshimura, A. et al., Cutting edge: role of IL-27/WSX-1 signaling for induction of T-bet through activation of STAT1 during initial Th1 commitment. J. Immunol. 2003. 170: 48864890.
  • 32
    Gatto, L., Berlato, C., Poli, V., Tininini, S., Kinjyo, I., Yoshimura, A., Cassatella, M. A. et al., Analysis of SOCS-3 promoter responses to interferon gamma. J. Biol. Chem. 2004. 279: 1374613754.
  • 33
    Frank, D. A., Mahajan, S. and Ritz, J., Fludarabine-induced immunosuppression is associated with inhibition of STAT1 signaling. Nat. Med. 1999. 5: 444447.
  • 34
    Furukawa, M., Takaishi, H., Takito, J., Yoda, M., Sakai, S., Hikata, T., Hakozaki, A. et al., IL-27 abrogates receptor activator of NF-kappa B ligand-mediated osteoclastogenesis of human granulocyte-macrophage colony-forming unit cells through STAT1-dependent inhibition of c-Fos. J. Immunol. 2009. 183: 23972406.
  • 35
    Brender, C., Tannahill, G. M., Jenkins, B. J., Fletcher, J., Columbus, R., Saris,C. J., Ernst, M. et al., SOCS3 regulates CD8 T cell proliferation by inhibition of IL-6 and IL-27. Blood 2007. 110: 25282536.
  • 36
    Guzzo, C., Che Mat, N. F. and Gee, K., Interleukin-27 induces a STAT1/3- and NF-kappaB-dependent proinflammatory cytokine profile in human monocytes. J. Biol. Chem. 2010. 285: 2440424411.
  • 37
    Larousserie, F., Charlot, P., Bardel, E., Froger, J., Kastelein, R. A. and Devergne, O., Differential effects of IL-27 on human B cell subsets. J. Immunol. 2006. 176: 58905897.
  • 38
    Chapgier, A., Kong, X. F., Boisson-Dupuis, S., Jouanguy, E., Averbuch, D., Feinberg, J., Zhang, S. Y. et al., A partial form of recessive STAT1 deficiency in humans. J. Clin. Invest. 2009. 119: 15021514.
  • 39
    Morishima, N., Mizoguchi, I., Okumura, M., Chiba, Y., Xu, M., Shimizu, M., Matsui, M. et al., A pivotal role for interleukin-27 in CD8+T cell functions and generation of cytotoxic T lymphocytes. J. Biomed. Biotechnol. 2010. 2010: 605483.
  • 40
    Yoshida, H., Nakaya, M. and Miyazaki, Y., Interleukin 27: a double-edged sword for offense and defense. J. Leukoc. Biol. 2009. 86: 12951303.
  • 41
    Schmidt, C., Giese, T., Ludwig, B., Mueller-Molaian, I., Marth, T., Zeuzem, S., Meuer, S. C. et al., Expression of interleukin-12-related cytokine transcripts in inflammatory bowel disease: elevated interleukin-23p19 and interleukin-27p28 in Crohn's disease but not in ulcerative colitis. Inflamm. Bowel Dis. 2005. 11: 1623.
  • 42
    Arbour, N., Holz, A., Sipe, J. C., Naniche, D., Romine, J. S., Zyroff, J. and Oldstone, M. B., A new approach for evaluating antigen-specific T cell responses to myelin antigens during the course of multiple sclerosis. J. Neuroimmunol. 2003. 137: 197209.